US Bancorp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.6M Sell
166,108
-5,813
-3% -$3.15M 0.1% 149
2025
Q4
$99.6M Sell
171,921
-1,273
-0.7% -$720K 0.12% 135
2025
Q3
$84M Sell
173,194
-439
-0.3% -$204K 0.1% 142
2025
Q2
$70.4M Sell
173,633
-4,300
-2% -$1.8M 0.09% 160
2025
Q1
$88.5M Sell
177,933
-2,709
-1% -$1.47M 0.12% 135
2024
Q4
$94M Sell
180,642
-7,009
-4% -$3.85M 0.12% 133
2024
Q3
$116M Sell
187,651
-1,778
-0.9% -$1.05M 0.15% 120
2024
Q2
$105M Sell
189,429
-507
-0.3% -$290K 0.14% 120
2024
Q1
$110M Sell
189,936
-3,142
-2% -$1.76M 0.15% 122
2023
Q4
$102M Sell
193,078
-2,359
-1% -$1.14M 0.15% 123
2023
Q3
$98.9M Buy
195,437
+323
+0.2% +$172K 0.16% 119
2023
Q2
$102M Sell
195,114
-3,265
-2% -$1.76M 0.16% 118
2023
Q1
$114M Sell
198,379
-311
-0.2% -$175K 0.19% 108
2022
Q4
$109M Sell
198,690
-4,371
-2% -$2.32M 0.19% 112
2022
Q3
$103M Sell
203,061
-5,230
-3% -$2.93M 0.21% 100
2022
Q2
$113M Sell
208,291
-4,456
-2% -$2.45M 0.22% 99
2022
Q1
$126M Sell
212,747
-161
-0.1% -$92.5K 0.21% 101
2021
Q4
$142M Buy
212,908
+1,293
+0.6% +$807K 0.22% 98
2021
Q3
$121M Sell
211,615
-3,571
-2% -$1.96M 0.23% 97
2021
Q2
$109M Buy
215,186
+5,535
+3% +$2.61M 0.2% 104
2021
Q1
$95.7M Sell
209,651
-976
-0.5% -$466K 0.19% 108
2020
Q4
$98.1M Buy
210,627
+7,796
+4% +$3.66M 0.21% 102
2020
Q3
$89.6M Sell
202,831
-6,171
-3% -$2.55M 0.22% 96
2020
Q2
$75.7M Buy
209,002
+304
+0.1% +$102K 0.2% 108
2020
Q1
$59.2M Buy
208,698
+1,842
+0.9% +$581K 0.18% 117
2019
Q4
$67.2M Sell
206,856
-2,610
-1% -$791K 0.17% 125
2019
Q3
$61M Sell
209,466
-4,095
-2% -$1.17M 0.17% 123
2019
Q2
$62.7M Sell
213,561
-9,373
-4% -$2.58M 0.17% 123
2019
Q1
$61M Buy
222,934
+3,595
+2% +$895K 0.18% 122
2018
Q4
$49.1M Sell
219,339
-9,155
-4% -$2.15M 0.16% 128
2018
Q3
$55.8M Sell
228,494
-4,428
-2% -$1.02M 0.16% 124
2018
Q2
$48.2M Sell
232,922
-3,031
-1% -$643K 0.15% 138
2018
Q1
$48.7M Sell
235,953
-1,693
-0.7% -$355K 0.15% 138
2017
Q4
$45.1M Buy
237,646
+4,278
+2% +$820K 0.14% 146
2017
Q3
$44.2M Buy
233,368
+3,690
+2% +$668K 0.14% 140
2017
Q2
$40.1M Buy
229,678
+9,408
+4% +$1.58M 0.13% 145
2017
Q1
$33.8M Buy
220,270
+4,747
+2% +$726K 0.12% 162
2016
Q4
$30.4M Sell
215,523
-2,309
-1% -$340K 0.11% 166
2016
Q3
$34.6M Sell
217,832
-1,694
-0.8% -$261K 0.13% 152
2016
Q2
$32.4M Buy
219,526
+4,239
+2% +$626K 0.12% 157
2016
Q1
$30.5M Sell
215,287
-371
-0.2% -$49.7K 0.12% 158
2015
Q4
$30.6M Sell
215,658
-2,100
-1% -$280K 0.12% 153
2015
Q3
$26.6M Buy
217,758
+251
+0.1% +$32.7K 0.11% 169
2015
Q2
$28.2M Buy
217,507
+6,107
+3% +$796K 0.11% 169
2015
Q1
$28.4M Sell
211,400
-2,563
-1% -$330K 0.11% 163
2014
Q4
$26.8M Sell
213,963
-345
-0.2% -$42K 0.1% 177
2014
Q3
$26.1M Sell
214,308
-1,097
-0.5% -$133K 0.11% 172
2014
Q2
$25.4M Buy
215,405
+2,539
+1% +$299K 0.1% 173
2014
Q1
$25.6M Sell
212,866
-2,518
-1% -$299K 0.1% 166
2013
Q4
$24M Sell
215,384
-9,690
-4% -$964K 0.1% 171
2013
Q3
$20.7M Sell
225,074
-26,460
-11% -$2.39M 0.09% 168
2013
Q2
$21.3M Buy
+251,534
New +$20.9M 0.1% 161

Other funds holding TMO

US Bancorp's TMO Position: Q1 2026 in Review

US Bancorp reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q1 2026, selling an estimated $3.15M and leaving 166,108 shares worth $81.6M. The position accounts for 0.1% of the portfolio, ranked #149.

US Bancorp first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • US Bancorp held 166,108 shares of Thermo Fisher Scientific worth $81.6M as of Q1 2026.
  • US Bancorp sold 5,813 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.15M.
  • Thermo Fisher Scientific made up 0.1% of US Bancorp's portfolio in Q1 2026, its #149 holding.
  • US Bancorp first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Thermo Fisher Scientific position peaked at $142M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.